Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKCOM Regulatory News (KCOM)

  • There is currently no data for KCOM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - KCOM Group plc

25 Apr 2019 14:01

Teleios Capital Partners - Form 8.3 - KCOM Group plc

Teleios Capital Partners - Form 8.3 - KCOM Group plc

PR Newswire

London, April 25

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Teleios Capital Partners LLC, on behalf of discretionary investment clients
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeKCOM Group plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:N/A
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure24 April 2019
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”N/A

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:10p ordinary
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:83,127,58616.09
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:83,127,58616.09

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?No

Date of disclosure:25th April 2019
Contact name:Carl Speck
Telephone number*:+41 41 506 56 59

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
5th Jun 20187:31 amRNSReplacement: Final Results
5th Jun 20187:00 amRNSFinal Results
4th Jun 20187:00 amRNSAppointment of interim Chief Financial Officer
21st May 201811:48 amRNSDirector/PDMR Shareholding
17th May 201812:00 pmRNSDirectorate Change
25th Apr 20187:00 amRNSDirector/PDMR Shareholding
15th Mar 201811:55 amRNSDirector/PDMR Shareholding
22nd Feb 201812:00 pmRNSManagement Succession
16th Feb 20184:03 pmRNSDirector/PDMR Shareholding
14th Feb 201812:09 pmRNSDirector/PDMR Shareholding
2nd Feb 201810:15 amRNSBlock listing Interim Review
1st Feb 20187:00 amRNSCapital Markets Day
30th Jan 20189:49 amRNSDirector/PDMR Shareholding
29th Jan 20187:00 amRNSTrading Update and Management Change
13th Dec 20173:02 pmRNSDirector/PDMR Shareholding
6th Dec 201710:30 amRNSHolding(s) in Company
28th Nov 20177:00 amRNSHalf-year Report
20th Nov 20177:00 amRNSDirector/PDMR Shareholding
3rd Nov 20171:30 pmRNSNotice of Results
12th Oct 20172:28 pmRNSDirector/PDMR Shareholding
13th Sep 20174:09 pmRNSDirector/PDMR Shareholding
24th Aug 20175:35 pmRNSDirector/PDMR Shareholding
14th Aug 201711:26 amRNSDirector/PDMR Shareholding
1st Aug 20177:00 amRNSBlock listing Interim Review
21st Jul 20174:25 pmRNSResult of AGM
21st Jul 20177:00 amRNSTrading Update
18th Jul 20174:41 pmRNSDirector/PDMR Shareholding
10th Jul 20176:20 pmRNSDirector/PDMR Shareholding
22nd Jun 20171:33 pmRNSAnnual Financial Report
21st Jun 201711:53 amRNSHolding(s) in Company
16th Jun 201711:08 amRNSDirector/PDMR Shareholding
12th Jun 20174:21 pmRNSNotice of AGM
6th Jun 20177:00 amRNSFinal Results
30th May 20177:00 amRNSChange of Adviser
25th May 201711:37 amRNSHolding(s) in Company
23rd May 20174:47 pmRNSHolding(s) in Company
22nd May 201712:02 pmRNSHolding(s) in Company
11th May 20174:02 pmRNSDirector/PDMR Shareholding
28th Apr 201710:46 amRNSDirector Declaration
20th Apr 20177:00 amRNSHolding(s) in Company
20th Apr 20177:00 amRNSHolding(s) in Company
12th Apr 20171:29 pmRNSDirector/PDMR Shareholding
12th Apr 20171:16 pmRNSHolding(s) in Company
10th Apr 20174:41 pmRNSHolding(s) in Company
17th Mar 20174:15 pmRNSDirector/PDMR Shareholding
15th Feb 20179:13 amRNSDirector/PDMR Shareholding
9th Feb 20177:00 amRNSDirector/PDMR Shareholding
3rd Feb 20173:34 pmRNSBlock listing Interim Review
26th Jan 20174:42 pmRNSHolding(s) in Company
17th Jan 201710:28 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.